Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance of 14C-FYU-981 in Healthy Male Subjects
NCT02901366Phase 2Completed
- Sponsor
- Fuji Yakuhin
- Start
- Sep 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dotinurad in hyperuricemia, gout, sponsored by Fuji Yakuhin. Started Sep 2016; status: completed.
02
Drugs
dotinurad
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on NCT02901366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02901366.